Effect of alvitili on immunological parameters in often ailing children.

Natalia Yu Sotnikova, Olga A Gromova, Anna V Kudryashova, Valentina V Vtorushina
{"title":"Effect of alvitili on immunological parameters in often ailing children.","authors":"Natalia Yu Sotnikova,&nbsp;Olga A Gromova,&nbsp;Anna V Kudryashova,&nbsp;Valentina V Vtorushina","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The problem of the rehabilitation of often ailing children is not yet elucidated despite of a substantial amount of research done in this field. It is acknowledged that the impairment of immune reactivity is a pathogenetic foundation of often and prolonged respiratory diseases in children. In this connection, the aim of the study was to evaluate the effect of alvitili on the main immunologic parameters in children who get ill frequently. Alvitili, produced by Solvay Pharma (France), is one of the promising vitamin preparations that contain all necessary water-soluble and oil-soluble vitamins. Thirty children 3-8 years of age were selected for the study: 15 children were included in the group of often ailing children and 15 healthy children made the control group. Immunological examination was carried out using standard methods before and after administration of alvitili at a dose of 5 ml 3 times a day for 3 weeks. Alvitili normalized originally decreased levels of T lymphocytes and T helpers, enhanced expression of early activation markers on the surface of T lymphocytes and T helpers, normalized the number of HLA DR(+) T cells and the level of MIF production. The drug stimulated IgM synthesis, expression of FcgammaRIII on the surface of neutrophils and normalized the IgG level. The study showed that alvitili is an effective remedy in the rehabilitation of ill children, since it compensates a vitamin deficiency that is frequently seen in often-ailing children, and it normalizes various immunological parameters.</p>","PeriodicalId":21507,"journal":{"name":"Russian journal of immunology : RJI : official journal of Russian Society of Immunology","volume":"8 1","pages":"61-7"},"PeriodicalIF":0.0000,"publicationDate":"2003-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian journal of immunology : RJI : official journal of Russian Society of Immunology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The problem of the rehabilitation of often ailing children is not yet elucidated despite of a substantial amount of research done in this field. It is acknowledged that the impairment of immune reactivity is a pathogenetic foundation of often and prolonged respiratory diseases in children. In this connection, the aim of the study was to evaluate the effect of alvitili on the main immunologic parameters in children who get ill frequently. Alvitili, produced by Solvay Pharma (France), is one of the promising vitamin preparations that contain all necessary water-soluble and oil-soluble vitamins. Thirty children 3-8 years of age were selected for the study: 15 children were included in the group of often ailing children and 15 healthy children made the control group. Immunological examination was carried out using standard methods before and after administration of alvitili at a dose of 5 ml 3 times a day for 3 weeks. Alvitili normalized originally decreased levels of T lymphocytes and T helpers, enhanced expression of early activation markers on the surface of T lymphocytes and T helpers, normalized the number of HLA DR(+) T cells and the level of MIF production. The drug stimulated IgM synthesis, expression of FcgammaRIII on the surface of neutrophils and normalized the IgG level. The study showed that alvitili is an effective remedy in the rehabilitation of ill children, since it compensates a vitamin deficiency that is frequently seen in often-ailing children, and it normalizes various immunological parameters.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
活络素对常病儿童免疫指标的影响。
尽管在这一领域进行了大量的研究,但经常生病的儿童的康复问题尚未得到阐明。免疫反应性的损害是儿童呼吸道疾病的发病基础。在这方面,本研究的目的是评估活络菌对经常生病的儿童的主要免疫参数的影响。由法国索尔维制药公司(Solvay Pharma)生产的Alvitili是一种很有前途的维生素制剂,它含有所有必需的水溶性和油溶性维生素。选取30名3-8岁的儿童进行研究,其中15名儿童为常病儿童组,15名健康儿童为对照组。在给药前后用标准方法进行免疫检查,每次5ml,每天3次,连续3周。Alvitili使原本降低的T淋巴细胞和T辅助细胞水平正常化,增强T淋巴细胞和T辅助细胞表面早期活化标记物的表达,使HLA DR(+) T细胞数量和MIF产生水平正常化。该药刺激IgM合成,中性粒细胞表面表达FcgammaRIII,使IgG水平正常化。该研究表明,活络菌素是一种有效的治疗疾病儿童康复的药物,因为它弥补了经常生病的儿童中常见的维生素缺乏症,并使各种免疫参数正常化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Levels of TREC and KREC molecules significance determining in peripheral blood for predicting the outcome of COVID-19 disease in the acute period Characteristic changes of extracellular Dna levels, indices of netosis and inflammation in peripheral blood in patients with asthma Contents of matrix metalloproteinase type 2 (MMP-2) and complexes MMP-9/TIMP-1, MMP-2/TIMP-2, and total cholesterol in practically healthy people and patients with hypertension Immunological and biochemical markers of adverse outcome in COVID-19 and arterial hypertension Clinical and immunological efficacy of immunomodulating hexapeptide associated with the restoration of CD11b<sup>+</sup>CD64<sup>-</sup>CD32<sup>+</sup>CD16<sup>+</sup> and CD11b<sup>+</sup>CD64<sup>+</sup>CD32<sup>+</sup>CD16<sup>+</sup> neutrophil granulocytes subset in women with chronic infectious and inflammatory diseases of the pelvic organs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1